ENTX
NASDAQ · Biotechnology
Entera Bio Ltd
$2.69
-0.06 (-2.00%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,519.7% upside
Low Target
$34.30
Average Target
$43.57
High Target
$49.66
Current Price
$2.69
Current
$2.69
$2.69
Target
$43.57
$43.57
$34.30
$43.57 avg
$49.66
Scenario Analysis
Bear Case
$34.30
1,175.1%
Low target
Base Case
$43.57
+1,519.7%
Avg target
Bull Case
$49.66
+1,746.1%
High target
Risk/Reward
1.5x
Balanced
Price in Context
52-Week High
$4.20
-36.0% from high
52-Week Low
$0.91
+195.6% from low
Target vs 52W High
$43.57
+937.4% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -3.3% |
| AMGN | Hold | 43 | 47% | $190.87 | -54.4% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +138.3% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -16.9% |
| REGN | Buy | 38 | 68% | $76.80 | -89.8% |
| MRNA | Hold | 30 | 37% | $149.45 | -24.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -65.3% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -43.4% |